Intranasal blood-brain barrier bypass enables sequential mitochondria-targeted bioengineered nanolamellar system for ischemic stroke therapy

Journal:

Nature Communications

Published:

2026-01-17

DOI:

10.1038/s41467-025-68024-5

Affiliations:

4

Authors:

15

Go to article

Institutions	Authors	Share
State Key Laboratory of Natural Medicines (SKLNM), CPU, China	6.500000	0.43
China Pharmaceutical University (CPU), China	6.500000	0.43
German Center for Neurodegenerative Diseases within the Helmholtz Association (DZNE), Germany	1.000000	0.07
Institute for Experimental Molecular Imaging (ExMI), Germany	1.000000	0.07

Interested in Neurosciences?